Close
Close
Treatment Database
rozanolixizumab
Trade Name not avaiable
Orphan Indication Myasthenia gravis
USA Market Approval
USA Designation Date 01-02-2019
Sponsor UCB, Inc.
1950 Lake Park Drive Building 2100
Smyrna, Georgia, 30080
More about Myasthenia gravis
Free Newsletter
Related Videos
by Abidemi Uruejoma
5,946 views
by Abidemi Uruejoma
6,732 views
by Abidemi Uruejoma
12,847 views